GlassScriptPhysician profile
Rajiv Singh
NPI 1467510909
$13,089.74
in general payments reported to CMS, 2019-2025
24 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,275 · 2020: $2,358 · 2021: $1,647 · 2022: $4,615 · 2023: $2,386 · 2024: $673 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,194.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,894.35 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $2,813.88 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $1,612.79 | 2019-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Medtronic Vascular, INC. | $1,177.17 | 2020 | |
| W. L. Gore & Associates, INC. | $599.07 | 2022-2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $589.39 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $533.69 | 2021-2022 | |
| Abiomed | $428.52 | 2019-2023 | Impella |
| Abbott Laboratories | $424.30 | 2021-2025 | Mitraclip, Coroflow |
| Philips North America LLC | $350.87 | 2023 | |
| Inari Medical, INC. | $321.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $220.94 | 2021-2022 | |
| Pfizer INC. | $210.09 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $199.34 | 2019-2023 | Definity |
| Atricure, INC. | $193.38 | 2020-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $146.72 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.02 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $92.52 | 2022-2023 | Camzyos |
| Heartflow, INC. | $51.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $45.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.37 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $25.22 | 2023 | Optimizer |
| B. Braun Interventional Systems INC. | $15.48 | 2023 | Z-Med |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.